THQ Price Forecast & CEF Analysis. Distribution · NAV · Discount · Expense Ratio · RSI · MACD | US Stocks Today
Full metrics table
💊 A healthcare-specialized closed-end fund (CEF) managed by Avadin, which primarily invests in healthcare companies such as pharmaceuticals, biotechnology, and medical devices, seeking both income and capital appreciation through monthly distributions and the use of leverage.
It runs 21% of assets on borrowed money.
Borrowing to buy more lifts gains and deepens losses. This is not the same as an ETF tracking 3x a day.
Against the value of what the fund holds it is 8.9% cheaper.
Its holdings are worth $20.88 per share, but it trades at $19.02. Over the past year it usually traded 1.4% below value, so it is cheaper now.
Over the past 1 year, roughly in the middle
8% below its 1-year high.
Traded more than usual. That is 244% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -22.1%. The S&P 500 did +56% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 11.42% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 19.6%.
Tap to view numbers
It ranks #521 of 1436 in the industry
Based on market cap of $777M.
FAQ
What kind of CEF is THQ?
THQ is a closed-end fund (CEF).
What is the distribution yield of THQ?
THQ's distribution yield is approximately 11.42%, paid out on a regular basis.
What is the 52-week high and low for THQ?
THQ has recorded a 52-week high of $20.39 and a low of $16.28.